FSD Pharma (CSE:HUGE, NASDAQ:HUGE) Inc (CSE:HUGE) (NASDAQ:HUGE) Interim CEO Anthony Durkacz tells Proactive the group is to buy Canada-based specialty psychedelic pharma group Lucid Psycheceuticals Inc in a stock deal worth around US$9 million (C$11.3 million). Durkacz says the life sciences holding company 's acquisition provided it with new assets at the forefront of new medicine and represented a 'paradigm shift' in its development.
FSD Pharma 'excited' to acquire pharma group Lucid Psycheceuticals to complement existing efforts
